Open an Account
search icon
4
NOTIFICATIONS
Best Algo trading app in India
Bigul

GENESYS INTERNATIONAL CORPORATION LTD. - 506109 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

 Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 please find enclosed herewith a copy of the statement scheduled to be released to the shareholders / investors on June 15, 2022. Genesys International, India's leading 3D Mapping Company receives an investment of Rs. 250 Cr equity led by Malabar India Fund and other Marquee Investors to strengthen its 3D Digital Twin Content Program'
15-06-2022
Bigul

GENESYS INTERNATIONAL CORPORATION LTD. - 506109 - Board Meeting Outcome for Outcome Of Board Meeting Held On June 14, 2022

 Further to our letter dated June 09, 2022 and with reference to the captioned matter, this is to inform you that the Board of Directors of the Company, at its meeting held today i.e. Tuesday, 14th June, 2022 have inter-alia, considered and approved following i. Issuance of securities on Preferential basis to Non Promoters ii. The Board approved Genesys Employee Stock Option Scheme - 2022 subject to approval of shareholders. iii. Consolidation of shareholding in subsidiary iv. The Board also approved convening of an Extra Ordinary General Meeting (EGM) of the members of the Company through Video Conferencing/ Other Audio Video means, on Saturday, July 09, 2022, along with the draft Notice to convene EGM. The meeting commenced at 8.30 p.m. and concluded at 10.10 p.m
14-06-2022
Bigul

GENESYS INTERNATIONAL CORPORATION LTD. - 506109 - Closure of Trading Window

 The trading window for dealing in Company's shares shall remain closed from June 10, 2022 until the expiry of 48 hours after publication (on NSE and BSE) of Outcome of Board meeting to be held on 14th June 2022 for approval of preferential issue of shares
09-06-2022
Bigul

GENESYS INTERNATIONAL CORPORATION LTD. - 506109 - Board Meeting Intimation for Approval Of Preferential Issue Of Shares

 GENESYS INTERNATIONAL CORPORATION LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/06/2022 ,inter alia, to consider and approve Proposal to raise funds by issuance of securities of the Company on a preferential basis subject to approval of Stock Exchanges and members of the Company and in accordance with the SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018, the Companies Act, 2013 and other applicable rules, regulations and guidelines. b. Proposal to consider and approve Employee Stock Option Scheme 2022. c. Proposal to seek shareholders' approval on aforesaid matters by calling an Extraordinary General Meeting. Further, as per the Company's Code of Conduct to regulate and monitor Insider Trading, the trading window for dealing in Company's shares shall remain closed from June 10, 2022 until the expiry of 48 hours after publication of Outcome of said Board meeting on National Stock Exchange of India Limited and Bombay Stock Exchange.
09-06-2022
Bigul

GENESYS INTERNATIONAL CORPORATION LTD. - 506109 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 Please find enclosed a copy of newspaper publication of Audited Standalone and Consolidated financial results of the Company for the quarter and financial year ended March 31, 2022 as published in the Newspaper - The Free Press Journal (English) and Navshakti (Marathi). Request you to take the same on records.
09-06-2022
Bigul

Annual report for Genesys International Corporation Ltd. for FY-2022
08-06-2022
Bigul

GENESYS INTERNATIONAL CORPORATION LTD. - 506109 - Statement Of Deviation Or Variation Or Utilization Of Funds Raised Under Preferential Issue - Regulation 32(1) Of SEBI (LODR) Regulations, 2015 For The Quarter And Financial Year Ended March 31, 2022

 In compliance with the Regulation 32(1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 please find attached the Statement of Deviation or Variation or Utilization of funds raised through Preferential Issue by the Company for the quarter and financial year ended March 31, 2022 as reviewed by the Audit Committee. You are requested to take the above on your records.
07-06-2022
Bigul

GENESYS INTERNATIONAL CORPORATION LTD. - 506109 - Board Meeting Outcome for Outcome Of Board Meeting Held On June 07, 2022

 In compliance with the provisions of Regulation 30 and 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors of the Company, at their meeting held today has inter alia considered and approved following:- 1. Audited Financial Results (Standalone & Consolidated) for the quarter and financial year ended March 31, 2022 along with the statement of Assets and Liabilities as at March 31, 2022. Copies of the following enclosed as Annexure A: a. Audited Financial Results (Standalone & Consolidated) for the quarter and financial year ended March 31, 2022. b. Auditors' Report along with a Declaration in respect of unmodified opinion on the Audited Financial Results. 2. Appointment of M/s H. C Vora & Associates as the Internal Auditors and M/s Roy Jacob & Co., Company Secretaries as the Secretarial Auditors of the Company for the financial year 2022-23.
07-06-2022
Bigul

GENESYS INTERNATIONAL CORPORATION LTD. - 506109 - Results- Financial Results For The Quarter And Financial Year Ended March 31, 2022.

 1. Audited Financial Results (Standalone & Consolidated) for the quarter and financial year ended March 31, 2022 along with the statement of Assets and Liabilities as at March 31, 2022. Copies of the following enclosed as Annexure -A a. Audited Financial Results (Standalone & Consolidated) for the quarter and financial year ended March 31, 2022. b. Auditors' Report along with a Declaration in respect of unmodified opinion on the Audited Financial Results. 2. Appointment of M/s H. C Vora & Associates as the Internal Auditors and M/s Roy Jacob & Co., Company Secretaries as the Secretarial Auditors of the Company for the financial year 2022-23.
07-06-2022
Bigul

GENESYS INTERNATIONAL CORPORATION LTD. - 506109 - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS

 The Compensation Committee at its meeting held on June 03, 2022 has approved the allotment of 44,470 equity shares of face value of Rs. 5.00 each pursuant to the exercise of the Stock Options by the eligible employees of the company under the Genesys ESOP Scheme -2020. Consequently, post-allotment the paid-up capital of the company shall stand increased to Rs. 15,73,33,965/- divided into 3,14,66,793 Equity Shares of face value of Rs. 5.00 each. These shares shall rank pari passu with the existing equity shares of the Company in all respects. You are requested to take the above on your record.
03-06-2022
Next Page
Close

Let's Open Free Demat Account